Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs

Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: Toward a novel active targeting strategy in breast cancer therapy

(2017) Lin Li et al.   Nanomedicine-Nanotechnology Biology and Medicine

Glutamine transporters in mammalian cells and their functions in physiology and cancer

(2016) Yangzom D. Bhutia et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy

(2016) Qiuhua Luo et al.   JOURNAL OF CONTROLLED RELEASE

Effect of surface ligand density on cytotoxicity and pharmacokinetic profile of docetaxel loaded liposomes

(2016) Chun Chu et al.   Asian Journal of Pharmaceutical Sciences

Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells

(2016) Leonardo Venturelli et al.   Scientific Reports

Cell Microenvironment-Controlled Antitumor Drug Releasing-Nanomicelles for GLUT1-Targeting Hepatocellular Carcinoma Therapy

(2015) Yubo Guo et al.   ACS Applied Materials & Interfaces

Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs

(2015) Y. D. Bhutia et al.   CANCER RESEARCH

Polypill treatments for cardiovascular diseases

(2015) Ruth Webster et al.   Expert Opinion on Drug Delivery

The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy

(2014) Yangzom D. Bhutia et al.   Asian Journal of Pharmaceutical Sciences

Choline transporter-targeting and co-delivery system for glioma therapy

(2013) Jianfeng Li et al.   BIOMATERIALS

Prodrug Design Targeting Intestinal PepT1 for Improved Oral Absorption: Design and Performance

(2013) Youxi Zhang et al.   CURRENT DRUG METABOLISM

Drug transport via the intestinal peptide transporter PepT1

(2013) Matthias Brandsch   CURRENT OPINION IN PHARMACOLOGY

The endocytosis and intracellular fate of nanomedicines: Implication for rational design

(2013) Longfa Kou et al.   Asian Journal of Pharmaceutical Sciences

Effect of ligand density, receptor density, and nanoparticle size on cell targeting

(2012) Drew R. Elias et al.   Nanomedicine-Nanotechnology Biology and Medicine

Abstract 3529: Cisplatin-induced downregulation of OCTN2 affects carnitine (vitamin BT) wasting

(2011) Chaoxin Hu et al.   CANCER RESEARCH

Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOs

(2011) Xiu Hong Shan et al.   EUROPEAN JOURNAL OF RADIOLOGY

Endocytosis of nanomedicines

(2010) Gaurav Sahay et al.   JOURNAL OF CONTROLLED RELEASE

Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1

(2010) Amir Fakhari et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond

(2008) Vadivel Ganapathy et al.   PHARMACOLOGY & THERAPEUTICS

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

(2008) F. Gu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA